Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Biomedicine Archive

  • A Contrarian in Biotech

    Peter Thiel was the first large investor in Facebook. Now he’s turning his investing skills to biotechnology.

    9 sidenotes

  • Brain Organoids

    A new method for growing human brain cells could unlock the mysteries of dementia, mental illness, and other neurological disorders.

    Availability: now


  • Liquid Biopsy

    Fast DNA-sequencing machines are leading to simple blood tests for cancer.

    Availability: now


  • Genome Editing

    The ability to create primates with intentional mutations could provide powerful new ways to study complex and genetically baffling brain disorders.


  • Genome Surgery

    Precise and easy ways to rewrite human genes could finally provide the tools that researchers need to understand and cure some of our most deadly genetic diseases.


  • A Tale of
    Two Drugs

    Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.



From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me